The role of rs267606943 polymorphism in the prolidase gene and plasma prolidase in polycystic ovary syndrome

被引：2

作者：

Bhatnager, R. ^{[1
]}

Nanda, S. ^{[2
]}

Dang, A. S. ^{[1
]}

机构：

[1] Maharshi Dayanand Univ, Ctr Med Biotechnol, Rohtak, Haryana, India

[2] Pandit Bhagwat Dayal Sharma Inst Med Sci, Rohtak, Haryana, India

来源：

BRITISH JOURNAL OF BIOMEDICAL SCIENCE | 2018年 / 75卷 / 03期

关键词：

PCOS; SNP; missense mutation; prolidase; polymorphism; PCOS; PREVALENCE; CRITERIA; CANCER;

D O I：

10.1080/09674845.2018.1455489

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：153 / 155

页数：3

共 13 条

[1]

Alexiou E, 2017, HORM MOL BIOL CLIN I, V29, P105, DOI 10.1515/hmbci-2016-0047

[2] Serum Prolidase Activity and Oxidative Status in Patients With Stage I Endometrial Cancer [J].

Arioz, Dagistan Tolga ;

Camuzcuoglu, Hakan ;

Toy, Harun ;

Kurt, Sefa ;

Celik, Hakim ;

Aksoy, Nurten .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (07) :1244-1247

[3] The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].

Azziz, Ricardo ;

Carmina, Enrico ;

Dewailly, Didier ;

Diamanti-Kandarakis, Evanthia ;

Escobar-Morreale, Hector F. ;

Futterweit, Walter ;

Janssen, Onno E. ;

Legro, Richard S. ;

Norman, Robert J. ;

Taylor, Ann E. ;

Witchel, Selina F. .

FERTILITY AND STERILITY, 2009, 91 (02) :456-488

[4] The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis [J].

Bozdag, Gurkan ;

Mumusoglu, Sezcan ;

Zengin, Dila ;

Karabulut, Erdem ;

Yildiz, Bulent Okan .

HUMAN REPRODUCTION, 2016, 31 (12) :2841-2855

[5] Enhanced prolidase activity and decreased collagen content in breast cancer tissue [J].

Cechowska-Pasko, Marzanna ;

Palka, Jerzy ;

Wojtukiewicz, Marek Z. .

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2006, 87 (04) :289-296

[6]

de Souza-Junior JE, 2015, J OPHTHALMOL, V2015

[7] PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].

DUNAIF, A ;

SEGAL, KR ;

FUTTERWEIT, W ;

DOBRJANSKY, A .

DIABETES, 1989, 38 (09) :1165-1174

[8] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].

Fauser, BCJM ;

Chang, J ;

Azziz, R ;

Legro, R ;

Dewailly, D ;

Franks, S ;

Tarlatzis, BC ;

Fauser, B ;

Balen, A ;

Bouchard, P ;

Dahlgren, E ;

Devoto, L ;

Diamanti, E ;

Dunaif, A ;

Filicori, M ;

Homburg, R ;

Ibanez, L ;

Laven, J ;

Magoffin, D ;

Nestler, J ;

Norman, RJ ;

Pasquali, R ;

Pugeat, M ;

Strauss, J ;

Tan, S ;

Taylor, A ;

Wild, R ;

Wild, S ;

Ehrmann, D ;

Lobo, R .

HUMAN REPRODUCTION, 2004, 19 (01) :41-47

[9] Increased prolidase activity and oxidative stress in PCOS [J].

Hilali, Nese ;

Vural, Mehmet ;

Camuzcuoglu, Hakan ;

Camuzcuoglu, Aysun ;

Aksoy, Nurten .

CLINICAL ENDOCRINOLOGY, 2013, 79 (01) :105-110

[10] Prolidase function in proline metabolism and its medical and biotechnological applications [J].

Kitchener, R. L. ;

Grunden, A. M. .

JOURNAL OF APPLIED MICROBIOLOGY, 2012, 113 (02) :233-247

← 1 2 →